GHRP-6
Ghrelin-mimetic GH secretagogue (investigational) · Pre-filled pen
GHRP-6 is a synthetic hexapeptide that acts as a ghrelin mimetic at the growth-hormone secretagogue receptor (GHS-R1a). It is understood to stimulate pituitary release of growth hormone and to activate hypothalamic appetite pathways, which is why marked hunger is a prominent and expected effect. Its actions are described mainly in early and preclinical research, and robust human outcome data are limited.
Studied use areas
- Investigated for growth-hormone release via the GHS-R1a pathway
- Studied for appetite and food-intake signalling
- Explored within body-composition and recovery research
- Researched as a comparator among ghrelin-mimetic secretagogues
Safety & status
- Strongly stimulates appetite and hunger — a prominent, expected effect to anticipate
- Investigational; robust human safety data are limited, use only under physician supervision
- Not for use in pregnancy or breastfeeding, or with active or suspected malignancy (GH-axis considerations)
⚕ Clinical note: GHRP-6 is an investigational, research-grade secretagogue and not an approved medicine. It is intended for physician-directed use only, and this content is educational, not medical advice.
Evidence: Grade D — investigational; limited human data, mainly preclinical · References: Bowers et al., Endocrinology 1984; Smith et al., Endocrine Reviews 1997; Sigalos & Pastuszak, Sexual Medicine Reviews 2018
